Photo Credit: Venti Views
Scientific Frontline: Extended "At a Glance" Summary: Genetic Map of the Human Eye
The Core Concept: Researchers have developed an unprecedentedly detailed genetic map illustrating how specific genetic variations dictate gene expression in the tissues responsible for human vision.
Key Distinction/Mechanism: By integrating whole-genome sequencing with RNA profiles from 201 human donor eyes, researchers identified over 1.4 million genetic signals—known as expression quantitative trait loci (eQTLs)—that act as regulatory switches to turn specific genes on or off within the neurosensory retina and the retinal pigment epithelium.
Major Frameworks/Components:
- Tissue-Specific Analysis: Focused mapping of the neurosensory retina (which captures light) and the retinal pigment epithelium (which nourishes the retina).
- eQTL Mapping: The identification of signals influencing the behavior of nearly 10,000 genes in the retina and 4,000 in the pigment epithelium.
- Expression Outliers: The pinpointing of nearly 300 rare genetic variants—including non-coding DNA changes and structural shifts—that explain unusually high or low retinal gene activity in specific individuals.
Branch of Science: Genetics, Ophthalmology, Molecular Biology, and Precision Medicine.
Future Application: The open-access dataset serves as a foundational roadmap to accelerate the development of personalized gene therapies, enable earlier diagnostic screening, and establish preventative interventions for patients at high risk of heritable vision loss.
Why It Matters: This comprehensive genomic resource exposes the complex biological mechanisms driving widespread, sight-threatening conditions like age-related macular degeneration (AMD), as well as rarer inherited disorders such as Stargardt disease and retinitis pigmentosa, offering new hope for mitigating visual impairment globally.
An international team led by University of Manchester scientists has created the most detailed picture yet of how genetic differences shape the way the human eye works.
The breakthrough could help explain why millions of people develop sight-threatening conditions such as age-related macular degeneration (AMD), as well as rarer inherited eye diseases.
The research is published today in Nature Communications.
Epidemiological research predicts that AMD, a leading cause of visual impairment in adults, will affect 288 million people worldwide by 2040.
Rarer inherited eye disorders, which interfere with cells in the retina that sense light and send visual signals to the brain, include Stargardt disease, retinitis pigmentosa, and cone-rod dystrophy.
The researchers analyzed whole-genome sequencing data alongside RNA profiles from 201 donated human eyes.
This allowed them to study two key tissues involved in vision: the neurosensory retina, which captures light, and the retinal pigment epithelium, which supports and nourishes it.
By comparing DNA differences with gene activity in these tissues, the researchers found more than 1.4 million genetic signals that influence how genes are turned on or off, known as expression quantitative trait loci, or eQTLs.
The signals influence how nearly 10,000 genes behave in the retina and almost 4,000 genes in the retinal pigment epithelium.
Many of the genetic effects were found in regions of the genome that act as regulatory switches, helping to turn genes on or off.
The study also identified hundreds of individuals whose retinal gene activity was unusually high or low compared with typical patterns.
Among these “expression outliers,” the researchers pinpointed nearly 300 rare genetic variants that could plausibly explain the unusual gene activity.
These variants included rare changes in parts of DNA that do not code for proteins, as well as larger structural shifts and differences in how many copies of certain DNA segments a person has.
Together, they accounted for approximately 28% of the outliers, offering new leads for understanding how rare mutations contribute to eye disease.
The findings provide an unprecedented resource for scientists studying the genetic roots of vision disorders, and they are accessible to other researchers.
They also offer a roadmap for future research into personalized treatments and earlier diagnosis.
Dr. Jamie Ellingford, an author from the University of Manchester, said, “Our study marks a major step toward decoding the complex genetic architecture of the human eye, and it opens the door to new strategies for protecting and restoring vision in the future. It reveals how both common and rare genetic differences shape the way they are expressed in the human retina. By understanding these patterns, we move closer to uncovering the biological mechanisms that drive heritable vision loss and to developing more targeted therapies.”
Jacob Sampson, a Ph.D. student at the University of Manchester who performed the extensive computational analysis reported in the study, added, “We hope this dataset will accelerate discoveries across ophthalmology, genetics, and precision medicine, and we hope it will support efforts to identify individuals at risk of sight-threatening disease before symptoms appear.”
Professor Simon J. Clark from the University of Tübingen in Germany said, “These sorts of fundamental discoveries are only possible by using very well characterized human donor material. We are incredibly lucky to have access to one of Europe’s largest human eye donor repositories, founded originally in Manchester back in 2015. We remain forever grateful for the generosity of all those donors and their families who contributed over the years.”
Funding: The research was supported by the Macular Society, Fight For Sight, the Medical Research Council and the NIHR Manchester Biomedical Research Centre.
Published in journal: Nature Communications
Authors: Jacob Sampson, Ayellet V. Segrè, Kinga M. Bujakowska, Simon J. Clark, Paul N. Bishop, Steve Haynes, Diana Baralle, Jospin Al-Deek, Stacey Holden, Beverley Anderson, Andrew Hayes, Rahmat A. Kemal, Huw B. Thomas, Raymond T. O’Keefe, Siddharth Banka, Graeme C. Black, Panagiotis I. Sergouniotis, and Jamie M. Ellingford
Source/Credit: University of Manchester
Edited by: Scientific Frontline
Reference Number: gen052626_01
.jpg)